G.E.S.T. Fellow in Hair and Nail diseases, Medical Dermatology, and Dermatopathology Fellowship Programme at “University of Miami Miller School of Medicine – Dr. Philip Frost Department of Dermatology and Cutaneous Surgery”, Miami, Florida
Fellowship Training Program in Mohs surgery and Cosmetic Dermatology at the Department of Dermatology at “Herbert Wertheim College of Medicine – Florida International University (FIU)” and “ Greater Miami Skin and Laser Center at Mount Sinai Medical Center”, Miami, Florida
Università degli studi di Napoli Federico II, Dipartimento di Medicina clinica e Chirurgia, Sezione di Dermatologia

Certificati

Foto

Competenze linguistiche

Italiano,
Inglese

Premi e riconoscimenti

Vincitore del prestigioso premio EUROPEO “John Stratigos Memorial Scholarship” conseguito durante il 31st European Academy of Dermatology and Venereology Congress
Vincitore del premio “EADV | 2024 - American Academy of Dermatology (AAD) Grant” per partecipare al ;AAD Annual Meeting in San Diego, California.
Vincitore del premio European Academy of Dermatology and Venereology Society Scholarship to attend the French Society of Dermatology’s Annual Meeting in Paris” from 5 to 9 December 2023, Paris, France.

Visualizza altre informazioni

Mostra tutte le informazioni

Pubblicazioni e articoli

Pubblicazioni (129)

Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation. Expert opinion on drug safety, 22(11), 1003–1010.

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas. Clinical, cosmetic and investigational dermatology, 16, 2637–2644.

JAK Inhibitors in Psoriatic Disease. Clin Cosmet Investig Dermatol. 2023;16:3129-3145.

Dupilumab associated inflammatory arthritis: a literature review. Clin Exp Dermatol. Published online November 27, 2023. doi:10.1093/ced/llad390

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics. Pediatric Health Med Ther. 2023;14:435-451.

PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy. J Eur Acad Dermatol Venereol. 2023 Dec 7. doi: 10.1111/jdv.19662.

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab. Clin Cosmet Investig Dermatol. 2023;16:3503-3507.

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data. Clinical, cosmetic and investigational dermatology, 16, 2525–2536.

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge. Biomedicines. 2023;11(8):2191.

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review. Clin Cosmet Investig Dermatol. 2023;16:2045-2059.

“Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire.” Dermatology practical & conceptual vol. 13,3 e2023177.

118. Martora F, Battista T, Ruggiero A, et al. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature. Viruses. 2023;15(7):1423.

Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study. Psoriasis (Auckl). 2022 Jul 14;12:205-212.

Persistent candidiasis infection during anti-IL-17 treatment for plaque psoriasis requiring biologic discontinuation: a case series and literature review. Int J Dermatol. 2023 Mar;62(3):e135-e137.

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review. Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793.

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis (Auckl). 2023 May 4;13:19-26.

A case of scalp psoriasis resistant to ixekizumab successfully treated with bimekizumab. JAAD Case Reports, 2023, ISSN 2352-5126, https://doi.org/10.1016/j.jdcr .

Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation. Expert Opin Drug Saf. 2023 Jun 19:1-8. doi: .

Comment on: Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination by Gambichler. J Eur Acad Dermatol Venereol. 2023 Jun 16. doi: 10.1111/jdv.19264.

Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation. Expert Opin Drug Saf. 2023 Jun 20:1-7. doi: .

ChatGPT and Dermatology: friends or foes? Clin Exp Dermatol. 2023 Jul 4:llad227. doi: 10.1093/ced/llad227.

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? Clin Cosmet Investig Dermatol. 2023 Jun 28;16:1677-1690. doi: 10.2147/CCID.S407812.

Reply to ;Dalbavancin for the treatment of severe hidradenitis suppurativa Journal of the European Academy of Dermatology and Venereology : JEADV, 37(11), e1328–e1329.

Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study. J. Clin. Med. 2023, 12, 3233. https://doi.org/10.3390/jcm12093233

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis. Front. Med. 10:1165098. doi: 10.3389/fmed

The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders. J. Clin. Med. 2023, 12, 2865. https://doi.org/10.3390/jcm12082865

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature. Medicina 2023, 59, 801. https://doi.org/10.3390/medicina59040801.

Comment on: ;Associations between hidradenitis suppurativa and dermatological conditions in adults: A national cross-sectional study by Brown et al. Clin Exp Dermatol. 2023 Apr 25:llad156. doi: 10.1093/ced/llad156

Hair Aging and Hair Disorders in Elderly Patients. Int J Trichology. 2022 Nov-Dec;14(6):191-196. doi: 10.4103/ijt.ijt_90_21. Epub 2023 Jan 31. PMID: 37034552; PMCID: PMC10075351.

Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study. Clin Cosmet Investig Dermatol. 2023 Mar 2;16:553-564. doi: 10.2147/CCID.S400679. PMID: 36896374; PMCID: PMC9989005.

Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study. Clin Cosmet Investig Dermatol. 2023 Feb 27;16:529-536. doi: 10.2147/CCID.S402183. PMID: 36873660; PMCID: PMC9983574.

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report. Case Rep Dermatol. 2023 Feb 14;15(1):35-39. doi: . PMID: 36817850; PMCID: PMC9929653.

Reply to oral ivermectin to treat scabies: a comparison of two different regimens;. Clin Exp Dermatol. 2023 Feb 14:llad060. doi: 10.1093/ced/llad060. Epub ahead of print. PMID: 36785516.

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection. Clin Cosmet Investig Dermatol. 2023 Feb 5;16:369-373. doi: 10.2147/CCID.S403294. PMID: 36776245; PMCID: PMC9911898.

Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opin Drug Saf. 2023 Jan;22(1):25-41. doi: Epub 2023 Feb 2. PMID: 36718762.

Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opin Drug Saf. 2023 Jan;22(1):43-58. doi: Epub 2023 Feb 3. PMID: 36718748.

Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine by Luo et al. Australas J Dermatol. 2023 Feb;64(1):e103-e105. doi: 10.1111/ajd.13984. Epub 2023 Jan 22. PMID: 36683345.

A unilateral slow-growing yellow nodule of the glans penis. Clin Exp Dermatol. 2023 Jan 20;48(1):48-50. doi: 10.1093/ced/llac013. PMID: 36669189.

Author reply to: Comment on: ;Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role? Clin Exp Dermatol. 2022;llac130. doi:10.1093/ced/llac130

Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data [published online ahead of print, 2023 Jan 4]. Immunol Res. 2023;1-28. doi: 022-09356-y

Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge. Expert Opin Drug Saf. 2022;21(12):1445-1451. doi:

A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab. J Cosmet Dermatol. 2023 Mar;22(3):1146-1148. doi: 10.1111/jocd.15543. Epub 2022 Nov 29. PMID: 36448190.

Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge. Expert Opin Drug Saf. 2022;21(10):1249-1257. doi:

Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real-life study. Dermatol Ther. 2022;35(12):e15941. doi:10.1111/dth.15941

Probiotic supplement combined with topical therapy in the treatment of mild to moderate acne: results from an Italian single centre interventional study. Ital J Dermatol Venerol. 2022;157(6):510-514. doi:

Towards Personalized Medicine in Psoriasis: Current Progress. Psoriasis (Auckl). 2022;12:231-250. Published 2022 Sep 1. doi:10.2147/PTT.S328460

Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series. An Bras Dermatol. 2022 Nov-Dec;97(6):819-822. doi: 10.1016/j.abd Epub 2022 Sep 5.

Comment on Morphoea following COVID-19 vaccination;. Clin Exp Dermatol. 2022;47(12):2312-2313. doi:10.1111/ced.15396

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. Clin Cosmet Investig Dermatol. 2022 Aug 16;15:1649-1658. doi: 10.2147/CCID.S364640.

Reply to Nail psoriasis: A rare mRNA COVID-19 vaccine reaction by Lamberti A et al. J Eur Acad Dermatol Venereol. 2022 Aug 22. doi: 10.1111/jdv.18537.

A case of linear psoriasis in a young patient with Down syndrome and review of the literature. J Cosmet Dermatol. 2022 Aug 18. doi: 10.1111/jocd.15317.

Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review by Pauluzzi et al. J Eur Acad Dermatol Venereol. 2022 Aug 16. doi: 10.1111/jdv.18503.

Reply to Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity by R. Molinier et al. J Eur Acad Dermatol Venereol. 2022 Aug 16. doi: 10.1111/jdv.18512.

New frontiers in personalized medicine in psoriasis. Expert Opin Biol Ther. 2022 Aug 16:1-3. doi: .

Teledermatology in the management of hidradenitis suppurativa: should we improve this service? J Cosmet Dermatol. 2022 Aug 11. doi: 10.1111/jocd.15292.

Reply to;Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study. J Am Acad Dermatol. 2022 Aug 7: 02423-9. doi: 10.1016/j.jaad .

Reply to;Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials participants: a systematic review by Ricardo JW et al. Int J Dermatol. 2022 Aug 7. doi: 10.1111/ijd.16379.

The impact of COVID-19 infection on psoriatic patients treated with biologics: an Italian experience. Clin Exp Dermatol. 2022 Jul 22:10.1111/ced.15336. doi: 10.1111/ced.15336.

Photodynamic therapy with 16 methyl aminolaevulinic acid and topic calcipotriol: A novel promising synergistic approach for the management of Hailey-Hailey disease. Photodiagnosis Photodyn Ther. 2022 Jul 16;39:103018. doi: 10.1016/j.pdpdt Epub ahead of print. PMID: 35850460.

Patients satisfaction with remote dermatology consultations during Covid-19 pandemic. Response to A qualitative assessment of patient satisfaction with remote dermatology consultations utilised during the UKs first wave of the Covid-19 pandemic in a single secondary care Dermatology department. Clin Exp Dermatol. 2022 Jul 7. doi: 10.1111/ced.15326.

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab. Case Rep Dermatol. 2022 May 30;14(2):138-143.

Reply to: Usage and perceptions of teledermatology in 2021: a survey of dermatologists; by Ahmad et al. Int J Dermatol. 2022 Jun 29. doi: 10.1111/ijd.16326.

Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting. Dermatol Ther. 2022 Jun 27:e15667.

The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre. Clin Exp Dermatol. 2022 Jun 21:10.1111/ced.15307. doi: 10.1111/ced.15307.

Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa. Clin Exp Dermatol. 2022 Jun 21:10.1111/ced.15306. doi: 10.1111/ced.15306.

Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study by Bawane J et al. J Eur Acad Dermatol Venereol. 2022 Jun 20.

Strategies adopted in a Southern Italy referral center to reduce adalimumab discontinuation: Response to Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?. Clin Exp Dermatol. 2022 Jun 14.

Tacrolimus ointment may improve the effectiveness of Adalimumab in patients affected by hidradenitis suppurativa: a novel promising treatment. Clin Exp Dermatol. 2022 Jun 14.

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge. Psoriasis: Targets and Therapy 2022, 12:127-137

Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study. Dermatol Ther. 2022 Apr 19:e15524.

Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients Assessment. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:661-673.

Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study. J Dermatolog Treat. 2022 May 29:1-8.

Response to Unexpected consequences of SARS-CoV-2 pandemic: scabies infestation. Clin Exp Dermatol. 2022 May 28.

Video and telephone teledermatology visits during COVID-19 in comparison: patients satisfaction, doubts, and concerns. Clin Exp Dermatol. 2022 Jun 3. doi: 10.1111/ced.15286.

Proactive vs. reactive psoriasis therapy: a long-term evaluation with dermoscopic and confocal microscopy assessment. Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2018-2024.

A Case of Chronic HCV Infection Reactivation in a Psoriasis Patient Treated with Guselkumab [published online ahead of print, 2022 Mar 7]. Curr Drug Saf. 2022;10.2174/1574886317666220307112926.

Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review. Biomedicines. 2022;10(2):455.

New-onset lichen planus arising after COVID-19 vaccination. Dermatol Ther. 2022;e15374.

A case of esophageal candidiasis in a psoriatic patient treated with ixekizumab: Should treatment be discontinued?. Dermatol Ther. 2022;e15361.

Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study. J Dermatolog Treat. 2022;1-5.

A case of erythrodermic psoriasis successfully treated with apremilast. Dermatol Ther. 2022;35(1):e15204.

Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study. Dermatol Ther. 2022;35(1):e15214.

MRI in Pregnancy and Precision Medicine: A Review from Literature. J Pers Med. 2021 Dec 23;12(1):9.

Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?. Clin Exp Dermatol. 2021;10.1111/ced.15052.

New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge? Biomedicines. 2021 Oct 15;9(10):1482.

Anti-interleukin-23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice. Clin Exp Dermatol. 2021;10.1111/ced.14979.

Reply to Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre by Sotiriou E et al. J Eur Acad Dermatol Venereol. 2021;10.1111/jdv.17665.

Neoadjuvant use of methotrexate in eosinophilic angiocentric fibrosis of upper lip and hard palate: A case report. Dermatol Ther. 2021;34(5):e15094.

An atypical ear nodule. Indian J Dermatol Venereol Leprol. 2021;1-2.

Impact of current antipsoriatic systemic treatments on male and female fertility: what endocrinologists need to know. Minerva Endocrinol (Torino). 2021 Sep;46(3):350-362.

Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis. J Clin Med. 2021;10(5):1031.

Guselkumab and risankizumab for psoriasis: a 44-week indirect real-life comparison. J Am Acad Dermatol. 2021;85(4):1028-1030.

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data. Drug Des Devel Ther. 2021;15:1135-1147.

Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. J Eur Acad Dermatol Venereol. 2021;35(7):1485-1492.

Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period. Arch Dermatol Res. 2021; .

Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective study. Dermatol Ther. 2021;34(1):e14673.

Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HS. Skin Appendage Disord. 2020;6(6):366-369.

Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series. J Am Acad Dermatol. 2021;84(4):e211-e212.

SMS support group in the management of acne: A useful tool to increase adherence to treatment. Dermatol Ther. 2021;34(1):e14663.

Community Knowledge About the Use, Reuse, Disinfection and Disposal of Masks and Filtering Facepiece Respirators: Results of a Study Conducted in a Dermatology Clinic at the University of Naples in Italy. J Community Health. 2021;46(4):786-793.

Low dose oral corticosteroids, microneedling, and topical 5-fluorouracil: A novel treatment for recalcitrant pediatric vitiligo. Pediatr Dermatol. 2021;38(1):322-323.

New emergent therapies for atopic dermatitis: A review of safety profile with respect to female fertility, pregnancy, and breastfeeding. Dermatol Ther. 2021;34(1):e14475.

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus. Case Rep Dermatol. 2020;12(2):155-158.

QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study. Int J Dermatol. 2021;60(3):352-357.

Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients quality of life. J Dermatolog Treat. 2022 May;33(3):1736-1737.

Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective study. Dermatol Ther. 2020;33(6):e14144.

Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience. J Dermatolog Treat. 2020;1-5.

Giant nodular melanoma of the nose in a 78-year-old female refusing complete excision. Dermatol Ther. 2020;33(6):e14056.

Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review. Dermatol Ther. 2020;33(6):e14046.

Skin Needling in Combination with Antimicrobial Peptides for the Treatment of Keloids: A Novel Perspective Proposal and Approach for Skin Scars. Dermatology. 2020;236(6):601-602.

A case of generalized granuloma annulare successfully treated by hydroxychloroquine. Dermatol Ther. 2020;33(6):e13894.

Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection. J Eur Acad Dermatol Venereol. 2020;34(11):1680-1682.

Teledermatology and chronic skin diseases: Real life experience in a Southern Italian Dermatologic Centre. Dermatol Ther. 2020;33(6):e13839.

Teledermatology for acne during COVID-19: high patients satisfaction in spite of the emergency. J Eur Acad Dermatol Venereol. 2020;34(11):1662-1663.

QuantiFERON-TB Gold conversion is not uncommon in patients with psoriasis undergoing anti-tumour necrosis factor-α therapy. Br J Dermatol. 2020 Nov;183(5):977-978.

Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa. Dermatol Ther. 2020;33(4):e13756.

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?. Med Hypotheses. 2020;143:109853.

Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome. Int Wound J. 2020;17(5):1528-1531.

Safety of dupilumab in atopic patients during COVID-19 outbreak. J Dermatolog Treat. 2020;1-2.

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy. J Dermatolog Treat. 2020;1.

Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis?. Int J Dermatol. 2020;59(8):e308-e309.

Chronic cutaneous ulcers management in dermatologic department during COVID-19 era. Int Wound J. 2020;17(5):1517-1518.

Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic. Clin Exp Dermatol. 2020;45(6):749.

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears. J Dermatolog Treat. 2020;31(4):328-329.

Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic. J Eur Acad Dermatol Venereol. 2020;34(6):e249.

Secukinumab during pregnancy: a case report and review of literature. J Dermatolog Treat. 2020;1-2.

Skin Needling in Combination with Antimicrobial Peptides for the Treatment of Keloids: A Novel Perspective Proposal and Approach for Skin Scars. Dermatology. 2020;236(6):601-602. doi: . Epub 2020 Jul 13. PMID: 32659756.

A case of severe psoriasis in a 84-year-old women successfully treated with ixekizumab. Dermatol Ther. 2020;33(3):e13299.

A case of erythrodermic psoriasis successfully treated with guselkumab. Dermatol Ther. 2020;33(2):e13238.

102 recensioni

Aggiungi una recensione

Punteggio generale

Tutte le recensioni contano e non possono essere rimosse o modificate dai dottori a proprio piacimento. Scopri come funziona il processo di moderazione delle recensioni.

Ordina recensioni per

Carmine

Profilo verificato

23 aprile 2024

Presso: Studio Dermatologico Ruggiero • visita dermatologica + mappatura nei

Controllo annuale effettuato dal Dottor Ruggiero.
Professionista attento, preciso, minuzioso, molto attento al lato comunicativo e di una preparazione superlativa. Ho effettuato una visita dermatologica ed una mappatura dei nei. Lo consiglio vivamente.

I.A.

Profilo verificato

23 aprile 2024 • Visita prenotata su MioDottore.it

• Presso: Studio Dermatologico Ruggiero • visita dermatologica

Molto preciso nello spiegare molto gentile e anche molto disponibile per aiutare il paziente a risolvere il problema in meno tempo possibile

M.M.

21 aprile 2024

Presso: Studio Dermatologico Ruggiero • visita di medicina estetica

Avevo già fatto dei trattamenti di medicina estetica in passato, per la prima volta mi sono rivolta al dottore. Dopo una visita ho deciso di ripetere un tratttamento con botox e un filler per le rughe ai lati della bocca. Risultato molto naturale come volevo. Ve lo consiglio molto!

Andrea La Rocca

21 aprile 2024

Presso: Studio Dermatologico Ruggiero • visita dermatologica

Ho effettuato con il dottore Ruggiero una visita tricologia. Spiegazioni dettagliate ma semplici così da farmi capire. Cura chiara e semplice da seguire. A 4 mesi comincio a vedere degli ottimi risultati. Mi sono trovato veramente bene. Grazie

Lucia A.

21 aprile 2024

Presso: Studio Dermatologico Ruggiero • visita dermatologica

Ho effettuato dal dottore il mio solito controllo nei annuale. Scrupoloso e preciso. Lo consiglio

Pamela Spezzaferro

Profilo verificato

20 aprile 2024 • Visita prenotata su MioDottore.it

• Presso: Studio Dermatologico Ruggiero • visita dermatologica

Il Dottore è stato estremamente disponibile ed esaustivo.
Tornerò sicuramente per un'altro consulto medico

Gaetano carpentiero

Profilo verificato

20 aprile 2024 • Visita prenotata su MioDottore.it

• Presso: Studio Dermatologico Ruggiero • visita dermatologica

Un vero professionista.. cordiale, simpatico, e ha peofessionalita' da vendere... consigliatissimo..

A.G.

Profilo verificato

19 aprile 2024 • Visita prenotata su MioDottore.it

• Presso: Studio Dermatologico Ruggiero • visita dermatologica

Il dottor Ruggiero è di una professionalità e competenza rare. Super disponibile, attento e scrupoloso. Lo consiglio vivamente!

A.D.M.

18 aprile 2024

Presso: Studio Dermatologico Ruggiero • visita di medicina estetica

Mi sono rivolta al dottore per iniezioni di botulino. Sono molto soddisfatta, metta a proprio agio. Mi è sembrato molto preparato ed il risultato ottenuto è fantastico. Tornerò sicuramente.

Aldo C.

18 aprile 2024

Presso: Studio Dermatologico Ruggiero • visita dermatologica

Mi era stato consigliato e devo dire che è stata davvero una bella scoperta. Davvero un bravo dermatologo. Mi sono rivolto a lui per praticare una visita tricologia. Esperto, attento e da spiegazioni chiare.

Mostra altro

Risposte ai pazienti

ha risposto a 54 domande da parte di pazienti di MioDottore

Domande su Follicolite

Buongiorno, ho mio figlio di 18 anni che da qualche anno soffre di una forma di follicolite acuta soprattutto sul cuoio capelluto, abbiamo interpellato 2 dermatologi che gli hanno prescritto degli antibiotici e crema locale, ma la situazione purtroppo migliora nel momento dell'assunzione dell'antibiotico ma subito dopo peggiora nuovamente..
grazie

In caso di follicolite recidivante potrebbe essere utilie effettuare tamponi con antibiogramma per facilitare la scelta della corretta terapia antibiotica.
Le consiglio di effettuare questo esame in caso di persistenza dei sintomi e rivolgersi quindi al dermarologonper impostare una terapia mirata

Sono 40+ anni che prendo
DEPAKIN. Come due giorni fa il mio medico mi ha ridotto il uso Fino a 0 nei prossimi 4 mesi. Ho perso I Capelli su davanti della testa. E possible la ricresita dopo che non uso piu' Depakin?

Salve, per poter rispondere alla sua domanda è sicuramente necessaria una visita dermatologica di persona per poter stabilire la tipologia di alopecia
poter iniziate il trattamento medico più adeguato al caso.

Vedi tutte le risposte

Tutti i contenuti pubblicati su MioDottore.it, specialmente domande e risposte, sono di carattere informativo e in nessun caso devono essere considerati un sostituto di una visita specialistica.

Specialista in Dermatologia e Venereologia, Tricologia e Medicina Estetica.

Attualmente lavoro presso la Clinica Dermatologica dell' Università di Napoli Federico II, dove continuo ad aggiornare le mie conoscenze mediche e a partecipare in qualità di relatore a congressi nazionali e internazionali.

Laureato con lode in Medicina e Chirurgia presso l'Università degli Studi di Napoli Federico II, presso cui ho proseguito poi il percorso di Specializzazione in Dermatologia e Venereologia (con votazione 50/50 e lode).

Durante gli anni di formazione, mi sono da sempre dedicato ai diversi ambiti della dermatologia, con particolare interesse alla dermatologia infiammatoria, dermatologia oncologica, diagnosi. prevenzione e trattamento dei tumori cutanei, ed alla chirurgia dermatologica.

Per completare la mia formazione ho effettuato un periodo di formazione negli Stati Uniti (USA), presso “University of Miami Miller School of Medicine – Dr. Philip Frost Department of Dermatology and Cutaneous Surgery”, Miami, Florida. Durante questa Fellowship internazionale ho perfezionato le mie conoscenze sulla patologia tricologica ed ungueale, apprendendo ed implementando le mie capacità diagnostico terapeutiche per le patologie tricologiche, oltre che nell'ambito della medicina estetica.

Nel tempo trascorso negli Stati Uniti, ho avuto la possibilità di implementare anche le mie conoscenze e tecniche di chirurgia dermatologica, laser-terapia e di medicina estetica, frequentando "Herbert Wertheim College of Medicine – Florida International University (FIU)” e “ Greater Miami Skin and Laser Center at Mount Sinai Medical Center”, Miami, Florida.

Alla fine di migliorare ed affinare le mie tecniche ed abilità in ambito di dermatologia e medicina estetica, ho frequentato il "Corso di perfezionamento in Dermatologia estetico-correttiva e Dermoscopia" presso l'Università di Napoli Federico II.

Per migliorare ed aggiornare la mia pratica sto attualmente frequentando il master di II livello in "Malattie infiammatorie cutanee croniche" presso l'Università di Napoli Federico II.

La passione per la dermatologia, e la voglia di migliorare le mie conoscenze ed abilità cliniche, si è concretizzata anche con una notevole attività svolta in ambito di ricerca scientifica, con particolare interesse per le patologie infiammatorie cutanee, incluse psoriasi, acne, idrosadenite suppurativa e dermatite atopica.
Ad oggi Autore di oltre 120 pubblicazioni scientifiche su riviste dermatologiche nazionali ed internazionali, sono stato inoltre invitato come relatore a numerosissimi congressi sia Italiani che Internazionali.

Ricerche correlate

Città vicino Casandrino

Dermatologi a Napoli

Dermatologi a Salerno

Dermatologi a Caserta

Dermatologi a Avellino

Dermatologi a Aversa

Altro (15)

Principali patologie trattate

Dermatite atopica a Casandrino

Micosi a Casandrino

Onicomicosi a Casandrino

Tinea capitis a Casandrino

Cisti sebacea a Casandrino

Altro (14)

Dr. Angelo Ruggiero

Dermatologo, Tricologo, Medico estetico Altro

Indirizzi (4)

Corso Carlo Alberto 90, Casandrino

Misure di sicurezza

Metodi di pagamento

Telefono

Risparmia tempo! Prenota online:

Prestazioni disponibili

Hai dubbi o domande?

Via Pablo Neruda 22, Caserta

Misure di sicurezza

Telefono

Risparmia tempo! Prenota online:

Prestazioni disponibili

Hai dubbi o domande?

Corso Umberto I 23, Napoli

Misure di sicurezza

Telefono

Risparmia tempo! Prenota online:

Prestazioni disponibili

Hai dubbi o domande?

Via Figurelle 27, Napoli

Misure di sicurezza

Telefono

Risparmia tempo! Prenota online:

Prestazioni disponibili

Hai dubbi o domande?

Prestazioni e prezzi

Esperienze

Pubblicazioni e articoli

Pubblicazioni

102 recensioni

Ordina recensioni per

Carmine

I.A.

M.M.

Andrea La Rocca

Lucia A.

Pamela Spezzaferro

Gaetano carpentiero

A.G.

A.D.M.

Aldo C.

Risposte ai pazienti

Su di me

Patologie trattate

Formazione

Specializzazioni

Tirocini

Premi e riconoscimenti

Informazioni sul prezzo

Hai dubbi o domande?

Informazioni sul prezzo

Hai dubbi o domande?

Informazioni sul prezzo

Hai dubbi o domande?

Informazioni sul prezzo

Hai dubbi o domande?

E' necessario il pagamento della tua visita